Clinical trial · Interventional
Healing Touch and Health-Related Quality of Life in Women With Breast Cancer Receiving Radiation Therapy
Healing Touch and Health-Related Quality of Life in Women With Breast Cancer in Women With Breast Cancer Receiving Radiation Therapy
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to evaluate the effectiveness of Healing Touch to improve health-related quality of life in women with breast cancer receiving radiation therapy. Research Hypothesis Healing Touch significantly improves health-related quality of life when compared to a placebo treatment, among women receiving radiation therapy for treatment of breast cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Neoplasms | Breast Neoplasm | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Healing Touch | Behavioral | — | UNRESOLVED |
| Sham treatment | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- 1
- description
- non-contact Healing Touch treatment for 20-30 minutes once a week during the course of radiation therapy
- interventionNames
- Behavioral: Healing Touch
- type
- SHAM_COMPARATOR
- label
- 2
- description
- A RN graduate assistant will provide a sham treatment of 20-30 minutes of presence.
- interventionNames
- Behavioral: Sham treatment
Primary outcomes (1)
- measure
- The primary outcome measure is the difference in the FACT-B total score from baseline, midpoint and end of study participation.
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Any female patient being treated with radiation therapy for a diagnosis of stage 0, I, or II breast cancer * Aged 18 years or greater * Understands written and spoken English * receiving 4, 5 or 6 weeks of radiation are eligible with a minimum study enrollment time of 4 weeks. Exclusion Criteria: * Anyone not meeting the above
References
Publications (0)
Data not yet available